Asimov.png

Asimov

R&D/Manufacturing

  • Funding stage: Series B
  • Technology type: Platform Technology
Membership category
Corporate

201 Brookline Ave Ste 1201, Boston, Massachusetts, 02215-4157, United States

Asimov at a glance

Asimov integrates mammalian synthetic biology, computer-aided design, and machine learning to advance the design and manufacture of biologics and gene therapies.

About Asimov

Asimov builds tools to program living cells. Their mammalian cell engineering platform advances the design and manufacture of biologics and gene therapies as well as enables an engineering mindset for next-generation medicines.

Therapeutic area(s)

Articles Asimov has contributed to